RxDoctor Payments Data

Matthew Bennett, MD

Orthopaedic Surgery · Johnson City, NYNPI 1831118199

Payments from drug & device makers

$5,551in general payments, 2019–2025

Across 128 payments — averaging $43.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • MML US, Inc.$3K
  • Medtronic$1K
  • Nevro Corp.$365
  • SPR Therapeutics, Inc$220
  • AbbVie$192
  • Boston Scientific$153
  • plus $439 from 7 others

What the payments were for

  • Travel & lodging$1,59929%
  • Food & beverage$3,95171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
MML US, Inc.71$3,094
Medtronic(2 entities)14$1,087
Nevro Corp.9$365
SPR Therapeutics, Inc12$220
AbbVie2$192
Boston Scientific3$153
Stryker1$135
Abbott2$100
Stimwave Technologies Incorporated1$58
Vertex2$47
Scilex Pharmaceuticals Inc.2$43
Si-bone, Inc.7$31
Sentynl Therapeutics, Inc.2$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,551 in reported general payments places this provider in the 55th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$121,442
Medicare patients
360
Services billed
1,404

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naloxone Hcl11$711
Gabapentin46$368
Celecoxib11$299
Cephalexin11$115
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$39

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Johnson City

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →